Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.virol.2021.02.007 http://scihub22266oqcxt.onion/10.1016/j.virol.2021.02.007 33691216!7898979!33691216     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Virology 2021 ; 558 (ä): 1-12 Nephropedia Template TP {{tp|p=33691216|t=2021. Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines |pdf=|usr=}}{{33691216}} gab.com Text Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines JO: Virology http://www.kidney.de/pget.php?&tw=1&pmid=33691216 #FOAvip SARS-CoV-2 is a novel coronavirus, spread among humans, and to date, more than 100 million of laboratory-confirmed cases have been reported worldwide. The virus demonstrates 96% similarity to a coronavirus from a horseshoe bat and most probably emerged from a spill over from bats or wild animal(s) to humans. Currently, two variants are circulating in the UK and South Africa and spread to many countries around the world. The impact of mutations on virus replication, virulence and transmissibility should be monitored carefully. Current data suggest recurrent infection with SARS-CoV-2 correlated to the level of neutralising antibodies and with sustained memory responses following infection. Recently, remdesivir was FDA approved for treatment of COVID-19, however many potential antivirals are currently in different clinical trials. Clinical data and experimental studies indicated that licenced vaccines are helpful in controlling the disease. However, the current vaccines should be evaluated against the emerging variants of SARS-CoV-2. Twit Text FOAVip Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines ????Virology http://www.kidney.de/pget.php?&tw=1&pmid=33691216 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33691216 #FOAvip English Wikipedia <ref>{{Cite pmid|33691216}}</ref> Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines #MMPMID33691216 Abdel-Moneim AS; Abdelwhab EM; Memish ZA Virology 2021[Jun]; 558 (ä): 1-12 PMID33691216show ga SARS-CoV-2 is a novel coronavirus, spread among humans, and to date, more than 100 million of laboratory-confirmed cases have been reported worldwide. The virus demonstrates 96% similarity to a coronavirus from a horseshoe bat and most probably emerged from a spill over from bats or wild animal(s) to humans. Currently, two variants are circulating in the UK and South Africa and spread to many countries around the world. The impact of mutations on virus replication, virulence and transmissibility should be monitored carefully. Current data suggest recurrent infection with SARS-CoV-2 correlated to the level of neutralising antibodies and with sustained memory responses following infection. Recently, remdesivir was FDA approved for treatment of COVID-19, however many potential antivirals are currently in different clinical trials. Clinical data and experimental studies indicated that licenced vaccines are helpful in controlling the disease. However, the current vaccines should be evaluated against the emerging variants of SARS-CoV-2. |*COVID-19/immunology/therapy/virology[MESH] |*SARS-CoV-2/classification/drug effects[MESH] |*Viral Zoonoses/epidemiology/therapy[MESH] |Animals[MESH] |Antiviral Agents/*therapeutic use[MESH] |COVID-19 Vaccines/*therapeutic use[MESH] |Humans[MESH] |Immunotherapy[MESH]Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines(epmc).pdf DeepDyve Pubget Overpricing